Adherence in ulcerative colitis: an overview

References

• BernickSJKaneSOptimizing use of 5-ASA in the treatment of ulcerative colitis: focus on patient compliance and adherencePatient Relat Outcome Meas20101576322915953
   PubMedGoogle Scholar
• KhanNAbbasAMBazzanoLAKolevaYNKrousel-WoodMLong-term oral mesalazine adherence and the risk of disease flare in ulcerative colitis: nationwide 10-year retrospective cohort from the veterans affairs healthcare systemAliment Pharmacol Ther201236875576422882428
   PubMed Web of Science ®Google Scholar
• SerupJLindbladAKMarotiMTo follow or not to follow dermatological treatment – a review of the literatureActa Derm Venereol200686319319716710573
   PubMed Web of Science ®Google Scholar
• KaneSVSystematic review: adherence issues in the treatment of ulcerative colitisAliment Pharmacol Ther200623557758516480396
   PubMed Web of Science ®Google Scholar
• HawthorneABRubinGGhoshSReview article: medication non-adherence in ulcerative colitis – strategies to improve adherence with mesalazine and other maintenance therapiesAliment Pharmacol Ther200827121157116618384664
   PubMed Web of Science ®Google Scholar
• KaneSShayaFMedication non-adherence is associated with increased medical health care costsDig Dis Sci20085341020102417934828
   PubMed Web of Science ®Google Scholar
• SabateEAdherence To Long-Term Therapies: Evidence For ActionGenevaWorld Health Organization2003 Available from: http://www.who.int/chp/knowledge/publications/adherence_report/en/Accessed August 25, 2016
   Google Scholar
• OsterbergLBlaschkeTAdherence to medicationN Engl J Med2005353548749716079372
   PubMed Web of Science ®Google Scholar
• HorneRParhamRDriscollRRobinsonAPatients’ attitudes to medicines and adherence to maintenance treatment in inflammatory bowel diseaseInflamm Bowel Dis200915683784419107771
   PubMed Web of Science ®Google Scholar
• KimSBKimKOJangBIDaegu-Gyeongbuk Gastrointestinal Study Group (DGSG)Patients’ beliefs and attitudes about their treatment for inflammatory bowel disease in KoreaJ Gastroenterol Hepatol201631357558026313162
   PubMed Web of Science ®Google Scholar
• SelingerCPEadenJJonesDBModifiable factors associated with nonadherence to maintenance medication for inflammatory bowel diseaseInflamm Bowel Dis201319102199220623899547
   PubMed Web of Science ®Google Scholar
• DignassALindsayJOSturmASecond European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current managementJ Crohns Colitis2012610991103023040451
   PubMed Web of Science ®Google Scholar
• ShaleMJRileySAStudies of compliance with delayed-release mesalazine therapy in patients with inflammatory bowel diseaseAliment Pharmacol Ther200318219119812869079
   PubMed Web of Science ®Google Scholar
• KaneSVCohenRDAikensJEHanauerSBPrevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitisAm J Gastroenterol200196102929293311693328
   PubMed Web of Science ®Google Scholar
• D’IncàRBertomoroPMazzoccoKVettoratoMGRumiatiRSturnioloGCRisk factors for non-adherence to medication in inflammatory bowel disease patientsAliment Pharmacol Ther200827216617217949472
   PubMed Web of Science ®Google Scholar
• PranteraCViscidoABianconeLFrancavillaAGiglioLCampieriMA new oral delivery system for 5-ASA: preliminary clinical findings for MMxInflamm Bowel Dis200511542142715867580
   PubMed Web of Science ®Google Scholar
• RileySAManiVGoodmanMJLucasSWhy do patients with ulcerative colitis relapse?Gut19903121791832311975
   PubMed Web of Science ®Google Scholar
• VavrickaSHofmannRGuillaumeXPrevalence and reasons for drug non-adherence in a European cohort of ulcerative colitis patients: the UCandME surveyJ Crohns Colitis20159Suppl 1S327
   Google Scholar
• NeiheiselMBWheelerKJRobertsMEMedication adherence part one: understanding and assessing the problemJ Am Assoc Nurse Pract2014261495524382862
   PubMed Web of Science ®Google Scholar
• LamWYFrescoPMedication adherence measures: an overviewBiomed Res Int2015201521704726539470
   PubMed Web of Science ®Google Scholar
• LeeJKGraceKAFosterTGHow should we measure medication adherence in clinical trials and practice?Ther Clin Risk Manag20073468569018472991
   PubMedGoogle Scholar
• CostaEGiardiniASavinMInterventional tools to improve medication adherence: review of literaturePatient Prefer Adherence201591303131426396502
   PubMed Web of Science ®Google Scholar
• KaneSVOvercoming adherence issues in ulcerative colitisGastroenterol Hepatol (N Y)200731079579921960790
   PubMedGoogle Scholar
• KaneSVStrategies to improve adherence and outcomes in patients with ulcerative colitisDrugs200868182601260919093702
   PubMed Web of Science ®Google Scholar
• EdigerJPWalkerJRGraffLPredictors of medication adherence in inflammatory bowel diseaseAm J Gastroenterol200710271417142617437505
   PubMed Web of Science ®Google Scholar
• LachaineJYenLBeaucheminCHodgkinsPMedication adherence and persistence in the treatment of Canadian ulcerative colitis patients: analyses with the RAMQ databaseBMC Gastroenterol2013132323363459
   PubMed Web of Science ®Google Scholar
• KaneSHuoDAikensJHanauerSMedication nonadherence and the outcomes of patients with quiescent ulcerative colitisAm J Med20031141394312543288
   PubMed Web of Science ®Google Scholar
• LevyRLFeldADIncreasing patient adherence to gastroenterology treatment and prevention regimensAm J Gastroenterol19999471733174210406229
   PubMed Web of Science ®Google Scholar
• GreenbergRNOverview of patient compliance with medication dosing: a literature reviewClin Ther1984655925996383611
   PubMed Web of Science ®Google Scholar
• San RomanALBermejoFCarreraEPérez-AbadMBoixedaDAdherence to treatment in inflammatory bowel diseaseRev Esp Enferm Dig (Madrid)2005974249257
   Web of Science ®Google Scholar
• RobinsonAHankinsMWisemanGJonesMMaintaining stable symptom control in inflammatory bowel disease: a retrospective analysis of adherence, medication switches and the risk of relapseAliment Pharmacol Ther20133853153823834298
   PubMed Web of Science ®Google Scholar
• MoodyGAJayanthiVProbertCSMac KayHMayberryJFLong-term therapy with sulphasalazine protects against colorectal cancer in ulcerative colitis: a retrospective study of colorectal cancer risk and compliance with treatment in LeicestershireEur J Gastroenterol Hepatol1996812117911838980937
   PubMed Web of Science ®Google Scholar
• EadenJAbramsKEkbomAJacksonEMayberryJColorectal cancer prevention in ulcerative colitis: a case-control studyAliment Pharmacol Ther2000142145153
   PubMed Web of Science ®Google Scholar
• BassiADoddSWilliamsonPBodgerKCost of illness of inflammatory bowel disease in the UK: a single centre retrospective studyGut200453101471147815361497
   PubMed Web of Science ®Google Scholar
• KripalaniSYaoXHaynesRBInterventions to enhance medication adherence in chronic medical conditions: a systematic reviewArch Intern Med2007167654055017389285
   PubMedGoogle Scholar
• LoftusEVJrA practical perspective on ulcerative colitis: patients’ needs from aminosalicylate therapiesInflamm Bowel Dis200612121107111317119384
   PubMed Web of Science ®Google Scholar
• KaneSHuoDMagnantiKA pilot feasibility study of once daily dosing versus conventional dosing mesalamine for maintenance of ulcerative colitisClin Gastroenterol Hepatol20031317017315017487
   PubMed Web of Science ®Google Scholar
• KammMALichtensteinGRSandbornWJRandomized trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitisGut200857789390218272546
   PubMed Web of Science ®Google Scholar
• DignassAVeermanHOnce versus twice-daily mesalazine (Pentasa) granules for the maintenance of remission in ulcerative colitis: results from a multinational randomised controlled trialGut200857Suppl 1A118268063
   PubMedGoogle Scholar
• LiWZhanZMJiangXLOnce daily vs multiple daily mesalamine therapy for mild to moderate ulcerative colitis: a meta-analysisColorectal Dis2016187O214O22327214762
   PubMed Web of Science ®Google Scholar
• PedersenNThielsenPMartinsenLeHealth: individualization of mesalazine treatment through a self-managed web-based solution in mild-to-moderate ulcerative colitisInflamm Bowel Dis201420122276228525248002
   PubMed Web of Science ®Google Scholar
• ElkjaerMShuhaibarMBurischJE-health empowers patients with ulcerative colitis: a randomised controlled trial of the web-guided ‘Constant-care’ approachGut201059121652166121071584
   PubMed Web of Science ®Google Scholar
• MoshkovskaTStoneMASmithRMBankartJBakerRMayberryJFImpact of a tailored patient preference intervention in adherence to 5-aminosalicylic acid medication in ulcerative colitis: results from an exploratory randomized controlled trialInflamm Bowel Dis20111791874188121830265
   PubMed Web of Science ®Google Scholar
• CastiglioneFColomboGLValentinoMCDi MatteoSBrunoGMPatients’ perception of adherence to therapy in ulcerative colitis: results of a survey to specialized centersValue Health2015187A629
   Web of Science ®Google Scholar
• MitraDHodgkinsPYenLDavisKLCohenRDAssociation between oral 5-ASA adherence and health care utilization and costs among patients with active ulcerative colitisBMC Gastroenterol20121213223006789
   PubMed Web of Science ®Google Scholar